Ikena Oncology (IKNA)
(Delayed Data from NSDQ)
$1.70 USD
+0.03 (1.80%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $1.70 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Earnings News For IKNA
-
Ikena Oncology Reports Second Quarter 2024 Financial Results
-
Ikena Oncology Reports First Quarter 2024 Financial Results and Corporate Update
-
Ikena Oncology Reports Fourth Quarter and Full Year 2023 Financial Results
-
Ikena Oncology Shares Initial Positive and Differentiated Dose Escalation Data from IK-930 Phase I Trial and Reports Third Quarter 2023 Financial Results
-
Ikena Oncology, Inc. (IKNA) Reports Q2 Loss, Lags Revenue Estimates
-
Ikena Oncology Reports Second Quarter 2023 Financial Results and Corporate Update
-
Ikena Oncology, Inc. (IKNA) Reports Q1 Loss, Tops Revenue Estimates
-
Ikena Oncology Reports First Quarter 2023 Financial Results and Highlights Advancements Across Targeted Oncology Pipeline
-
Ikena Oncology, Inc. (IKNA) Reports Q4 Loss, Tops Revenue Estimates
-
Ikena Oncology Reports Fourth Quarter and Full Year 2022 Financial Results
-
UPDATE -- Ikena Oncology Reports Third Quarter 2022 Financial Results and Provides a Corporate Update
-
Ikena Oncology, Inc. (IKNA) Reports Q3 Loss, Tops Revenue Estimates
-
Ikena Oncology Reports Third Quarter 2022 Financial Results and Provides a Corporate Update
-
Ikena Oncology, Inc. (IKNA) Reports Q2 Loss, Misses Revenue Estimates
-
Ikena Oncology, Inc. (IKNA) Reports Q1 Loss, Tops Revenue Estimates